Mainz Biomed BV
NASDAQ:MYNZ

Watchlist Manager
Mainz Biomed BV Logo
Mainz Biomed BV
NASDAQ:MYNZ
Watchlist
Price: 1.38 USD -1.43% Market Closed
Market Cap: 5.3m USD

Wall Street
Price Targets

MYNZ Price Targets Summary
Mainz Biomed BV

There are no price targets for MYNZ.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Mainz Biomed BV Competitors:
Price Targets
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
7% Downside
NIOX
Niox Group PLC
20% Upside
NTLA
Intellia Therapeutics Inc
318% Upside
CPRX
Catalyst Pharmaceuticals Inc
59% Upside
TWST
Twist Bioscience Corp
45% Upside
KALV
Kalvista Pharmaceuticals Inc
144% Upside
BSLN
Basilea Pharmaceutica AG
89% Upside
OPK
OPKO Health Inc
139% Upside

Revenue
Forecast

Revenue Estimate
Mainz Biomed BV

For the last 4 years the compound annual growth rate for Mainz Biomed BV's revenue is 16%. The projected CAGR for the next 3 years is 46%.

16%
Past Growth
46%
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mainz Biomed BV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Mainz Biomed BV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYNZ's stock price target?
Not Available

MYNZ doesn't have any price targets made by Wall Street professionals.

What is Mainz Biomed BV's Revenue forecast?
Projected CAGR
46%

For the last 4 years the compound annual growth rate for Mainz Biomed BV's revenue is 16%. The projected CAGR for the next 3 years is 46%.

Back to Top